GLENBROOK CROSSES 30% OWNERSHIP OF SENESTECH
Further investment remains conditional, while Glenbrook has paid for an outside marketing analysis to support its engagement.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Glenbrook Capital Management disclosed ownership of more than 30% of SenesTech (SNES) common shares and proposed changes to marketing and capital allocation. Its letter cited 40% topline growth in Q3 and a $4 million run rate. Glenbrook intends to remain a supportive long-term investor and would consider further investment subject to mutually acceptable terms and market conditions.
Glenbrook retained Sandstrom Partners at its own expense; the firm completed its analysis of SenesTech's business and is ready to share its advice. Glenbrook urged minimizing equity dilution and considering selective equity compensation instead of cash, with performance conditions and attention to dilution. It supported and voted for the recent increase in SenesTech's stock option plan. These are shareholder proposals, not announced actions by SenesTech's board.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate pointGlenbrook's investment position now represents more than 30% of SenesTech's outstanding common shares.
- Minor pointSandstrom Partners has completed its business analysis and is ready to share advice with SenesTech.
Negative
- Minor point. Forward-looking: it has not happened yet and may not happen.Further Glenbrook investment is conditional on mutually acceptable terms and market conditions.
- Minor pointSandstrom Partners' engagement was funded at Glenbrook's expense.
Details
Market Reaction – SNES
On Oct 19, the day this news came out, the latest delayed price for SNES is 6.65% above the previous close. Our momentum scanner has recorded 27 alerts for this stock so far that day. The latest delayed price is $0.69. Relative volume is exceptionally heavy at 15.8x the average.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Key Figures
- Ownership
- More than 30% of outstanding shares
- Glenbrook's SenesTech holding
- Topline growth
- 40%
- Q3, as cited in Glenbrook's letter
- Run rate
- $4 million
- Cited in Glenbrook's letter
Historical Context
-
Preliminary Q3 revenue topped $1 million with 40% sequential growth, which Glenbrook cited.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
equity dilution financial
reverse splits financial
ipo financial
forward-looking statements regulatory
stock option plan financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Glenbrook Believes Better Market Strategy and Sharpened Capitalization Focus Would Create Significant Upside
Matthew Szot, Chairman of the Board
SenesTech, Inc.
13430 North Dysart Road, Suite 105
October 19, 2026
Dear Matt,
I am writing to advise you that Glenbrook Capital Management ("GCM" or "we") is now a significant shareholder of SenesTech, Inc. ("SenesTech" or the "Company"), with holdings representing more than
For our part, GCM intends to remain a supportive long-term investor, and we have participated in every round to which we were invited, starting before and including the IPO. We may—or may not-- increase our holdings over time, opportunistically, since we believe that the Company is grossly undervalued considering the market opportunity. Our fellow shareholders have endured a recurring cycle of dilutive offerings and reverse splits. Your shareholders want to end this cycle. We will consider further investment in SenesTech, subject to mutually acceptable terms and market conditions. Our primary goal, however, is to minimize equity dilution, and all efforts should be addressed to this end going forward. We believe that getting traction in the business is the right place to start.
As backers of the Company since before the IPO, we have been frustrated by the degree to which the sales have lagged the game-changing nature of SenesTech products. The market is there, we all know it, so how do we better communicate with and educate potential users? Because we want to help address this conundrum we retained (at our expense) the internationally recognized branding and marketing strategy firm, Sandstrom Partners ("Sandstrom"). Having completed their exhaustive analysis of the Company's business, they are ready to share with you their conclusions and advice. If you retain them for SenesTech, this will extend to ensuring that your recently heralded Amazon sales advances continue. For example, messaging purchasers so that they fully understand how to effectively use both Evolve and ContraPest.
We think a sharpened focus on capital discipline can benefit SenesTech and all of its shareholders. We supported and voted in favor of the recent increase in the Company's stock option plan. We encourage the Company to consider selective use of equity-based compensation in place of cash compensation. Speaking as a shareholder, we believe the optics for the Company would be significantly stronger if equity was awarded as compensation in lieu of cash. A thoughtful approach, with performance conditions and attention to avoiding dilution, could conserve cash while more closely aligning the interests of the Board with shareholders.
Our desire is to work cooperatively with the Board and management team on practical measures designed to improve the Company's financial position and support operating priorities. We look forward to engaging directly in the near future.
Sincerely,
Glenbrook Capital Management
Media Contact:
ASC Advisors
Taylor Ingraham / Cassandra Dasco
Partner, ASC Advisors
tingraham@ascadvisors.com / cdasco@ascadvisors.com
203-992-1230
Investor Contact:
Richard Rudgley
richard@glenbrookcapital.net
650-441-9525
Grover Wickersham
CEO, Glenbrook Capital Management
Disclaimer and Cautionary Statement Regarding Forward-Looking Statements
This press release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein in any state to any person.
The information herein contains "forward-looking statements." Specific forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts and include, without limitation, words such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "potential," "targets," "forecasts," "seeks," "could," "should" or the negative of such terms or other variations on such terms or comparable terminology. Similarly, statements that describe our objectives, plans or goals are forward-looking. Forward-looking statements are subject to various risks and uncertainties and assumptions. There can be no assurance that any idea or assumption herein is, or will be proven, correct or that any of the objectives, plans or goals stated herein will ultimately be undertaken or achieved. If one or more of such risks or uncertainties materialize, or if Glenbrook underlying assumptions prove to be incorrect, the actual results may vary materially from outcomes indicated by these statements. Accordingly, forward-looking statements should not be regarded as a representation by Glenbrook that the future plans, estimates or expectations contemplated will ever be achieved.
View original content:https://www.prnewswire.com/news-releases/glenbrook-crosses-30-ownership-of-senestech-302912974.html
SOURCE Glenbrook Capital Management
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much of SenesTech does Glenbrook Capital Management own?
Glenbrook Capital Management holds more than 30% of SenesTech's outstanding common shares. Glenbrook intends to remain a supportive long-term investor, but further investment would depend on mutually acceptable terms and market conditions.
What changes is Glenbrook proposing at SenesTech?
Glenbrook is proposing a sharper marketing strategy, minimizing equity dilution and selective use of equity compensation instead of cash. Its compensation proposal includes performance conditions and attention to dilution. Glenbrook also paid Sandstrom Partners to analyze the business; that analysis is complete and available to share with SenesTech.